BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 12530326)

  • 1. CD1 antigen presentation and infectious disease.
    Dascher CC; Brenner MB
    Contrib Microbiol; 2003; 10():164-82. PubMed ID: 12530326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD1-restricted T cells in host defense to infectious diseases.
    Behar SM; Porcelli SA
    Curr Top Microbiol Immunol; 2007; 314():215-50. PubMed ID: 17593663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD1-Restricted T Cells at the Crossroad of Innate and Adaptive Immunity.
    Pereira CS; Macedo MF
    J Immunol Res; 2016; 2016():2876275. PubMed ID: 28070524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity.
    Cohen NR; Garg S; Brenner MB
    Adv Immunol; 2009; 102():1-94. PubMed ID: 19477319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD1: antigen presentation and T cell function.
    Brigl M; Brenner MB
    Annu Rev Immunol; 2004; 22():817-90. PubMed ID: 15032598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of CD1-mediated presentation of lipid antigens.
    Moody DB; Besra GS; Wilson IA; Porcelli SA
    Immunol Rev; 1999 Dec; 172():285-96. PubMed ID: 10631954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD1-specific T cells in microbial immunity.
    Gumperz JE; Brenner MB
    Curr Opin Immunol; 2001 Aug; 13(4):471-8. PubMed ID: 11498304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary immunodeficiency associated with defects in CD1 and CD1-restricted T cells.
    Zeissig S; Blumberg RS
    Ann N Y Acad Sci; 2012 Feb; 1250():14-24. PubMed ID: 22276638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD1 proteins: targets of T cell recognition in innate and adaptive immunity.
    Ulrichs T; Porcelli SA
    Rev Immunogenet; 2000; 2(3):416-32. PubMed ID: 11256748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid Antigen Presentation by CD1b and CD1d in Lysosomal Storage Disease Patients.
    Pereira CS; Pérez-Cabezas B; Ribeiro H; Maia ML; Cardoso MT; Dias AF; Azevedo O; Ferreira MF; Garcia P; Rodrigues E; Castro-Chaves P; Martins E; Aguiar P; Pineda M; Amraoui Y; Fecarotta S; Leão-Teles E; Deng S; Savage PB; Macedo MF
    Front Immunol; 2019; 10():1264. PubMed ID: 31214199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diverse antigen presentation by the Group 1 CD1 molecule, CD1c.
    Adams EJ
    Mol Immunol; 2013 Sep; 55(2):182-5. PubMed ID: 23127489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for human CD4+ T cells in the CD1-restricted repertoire: derivation of mycobacteria-reactive T cells from leprosy lesions.
    Sieling PA; Ochoa MT; Jullien D; Leslie DS; Sabet S; Rosat JP; Burdick AE; Rea TH; Brenner MB; Porcelli SA; Modlin RL
    J Immunol; 2000 May; 164(9):4790-6. PubMed ID: 10779786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD1-restricted adaptive immune responses to Mycobacteria in human group 1 CD1 transgenic mice.
    Felio K; Nguyen H; Dascher CC; Choi HJ; Li S; Zimmer MI; Colmone A; Moody DB; Brenner MB; Wang CR
    J Exp Med; 2009 Oct; 206(11):2497-509. PubMed ID: 19808251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineation of a CD1d-restricted antigen presentation pathway associated with human and mouse intestinal epithelial cells.
    van de Wal Y; Corazza N; Allez M; Mayer LF; Iijima H; Ryan M; Cornwall S; Kaiserlian D; Hershberg R; Koezuka Y; Colgan SP; Blumberg RS
    Gastroenterology; 2003 May; 124(5):1420-31. PubMed ID: 12730881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1 expression and CD1-restricted T cell activity in normal and tumour-bearing human liver.
    Kenna T; O'Brien M; Hogan AE; Exley MA; Porcelli SA; Hegarty JE; O'Farrelly C; Doherty DG
    Cancer Immunol Immunother; 2007 Apr; 56(4):563-72. PubMed ID: 16924493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of human CD4+ T cells by targeting MHC class II epitopes to endosomal compartments using human CD1 tail sequences.
    Niazi KR; Ochoa MT; Sieling PA; Rooke NE; Peter AK; Mollahan P; Dickey M; Rabizadeh S; Rea TH; Modlin RL
    Immunology; 2007 Dec; 122(4):522-31. PubMed ID: 17635609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular features of lipid-based antigen presentation by group 1 CD1 molecules.
    Le Nours J; Shahine A; Gras S
    Semin Cell Dev Biol; 2018 Dec; 84():48-57. PubMed ID: 29113870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD1 molecules efficiently present antigen in immature dendritic cells and traffic independently of MHC class II during dendritic cell maturation.
    Cao X; Sugita M; Van Der Wel N; Lai J; Rogers RA; Peters PJ; Brenner MB
    J Immunol; 2002 Nov; 169(9):4770-7. PubMed ID: 12391186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD1d-restricted "NKT" cells and myeloid IL-12 production: an immunological crossroads leading to promotion or suppression of effective anti-tumor immune responses?
    Gumperz JE
    J Leukoc Biol; 2004 Aug; 76(2):307-13. PubMed ID: 15123775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral danger signals control CD1d de novo synthesis and NKT cell activation.
    Raftery MJ; Winau F; Giese T; Kaufmann SH; Schaible UE; Schönrich G
    Eur J Immunol; 2008 Mar; 38(3):668-79. PubMed ID: 18253929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.